ClinicalTrials.gg
Sign In

Diabetes Complications clinical trials

The registry lists 267 studies for Diabetes Complications across more than 10 countries. 54 are recruiting or about to start. 86 of them are mainly about Diabetes Complications (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 8 narrower conditions too, such as Diabetic Foot: 3,177 studies, 605 open.

Get an email when these change. Save the Diabetes Complications studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
131
Recruiting
45
Status unknown
38
Terminated
22
Withdrawn
11
Active, not recruiting
9

Phase

Phase 2
40
Phase 3
22
Phase 1
14
Phase 4
14
Early Phase 1
2

Where

United States
83
Denmark
23
United Kingdom
17
Brazil
11
Italy
11
Germany
11

Who runs them

Florida Atlantic University (10) · University of Colorado, Denver (8) · University of Aarhus (6) · Centre Hospitalier Universitaire de Nīmes (3) · Goldfinch Bio, Inc. (3) · Hospital de Clinicas de Porto Alegre (3) · Ain Shams University (3) · Heidelberg University (3)

What is being tested here

Drugs under test in Diabetes Complications studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Finerenone102
Roxadustat101
Darbepoetin alfa101
Ranibizumab013
Relamorelin003
Empagliflozin002
P-Aminohippuric Acid002
Dapagliflozin002
GFB-887002
Benphothiamine002

Drug classes tested here Angiogenesis inhibitors 5 · SGLT2 inhibitors 4

Coming up

0phase 3 studies under way
20studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 45 Diabetes Complications studies recruiting now, 27 (60%) set no upper age limit and 12 (27%) stop at 75 or younger. 7 (16%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 7 (16%) take healthy volunteers.

Recruiting studies that take each age, of 45
AgeWomenMen
106 (13%)6 (13%)
1834 (76%)33 (73%)
3036 (80%)35 (78%)
4038 (84%)38 (84%)
5039 (87%)39 (87%)
6540 (89%)40 (89%)
7537 (82%)37 (82%)
8530 (67%)30 (67%)

Across all 267 studies, recruiting or not: 36% stop at 75 or younger and 16% at 65; 10% take children; 1% are for women only and 3% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Diabetes Complications studies take

Of 69 interventional studies with no phase under Diabetes Complications, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo12–41 · 69 studies—27 mo11–41 · 62 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 267. Browse all 267 → or search them.